Vaccinex Delivers Virtual Presentation at the Advances in Alzheimer's and Parkinson's Therapies AAT-AD/PDâ„¢ Focus Meeting 2020

Author's Avatar
Apr 07, 2020
Article's Main Image

Presentation highlighted the potential of the company’s lead candidate, the anti-SEMA4D antibody pepinemab, to regulate glial cell activation and neurodegeneration in Alzheimer’s and Huntington’s disease